Skip to main content

THE FIRST TREATMENT FOR EoE
PATIENTS AS YOUNG AS 1 YEAR OLD

DUPIXENT is indicated for the treatment of adult and pediatric patients aged 1 year and older, weighing at least 15 kg, with eosinophilic esophagitis (EoE).1
TRANSFORM THE WAY
YOU MANAGE EoE

Discover clinical, histologic,
and
endoscopic results1-3

APPROVED in children as
young as 1 year with EoE (≥15 kg)1

EXPLORE UP TO 52 WEEKS OF DATA FOR BOTH GROUPS1-3

DUPIXENT MyWay® Logo

DUPIXENT MyWay® is a patient support
program
that can help
enable access to
DUPIXENT
and offers financial assistance
for
eligible
patients, one-on-one nursing
support, and more.

DUPIXENT MyWay
ENROLLMENT FORMS

English Enrollment Form
Spanish Enrollment Form